Day: 2. November 2016

JCR Pharma will start clinical tests on enzyme therapy in brain using their brain cargo” technology”

JCR has developed a technology to pass the blood-brain barrier (J Brain Cargo”, based on anti-transferrin receptor antibody). The objective of the forthcoming clinical trials is the treatment of Hunter’s disease, a deficiency of iduronic acid 2-sulfatase (IDS) which leads to a lysosomal diseases, mucopolysaccharidosis-2. In IDS knock-out mice, the resulting disease could be treated […]

Scroll to top